Preprint Long-term serum spike protein persistence but no correlation with post-COVID syndrome, 2024, Fehrer, Scheibenbogen+

Discussion in 'Long Covid research' started by SNT Gatchaman, Nov 12, 2024.

  1. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights) Staff Member

    Messages:
    6,688
    Location:
    Aotearoa New Zealand
    Long-term serum spike protein persistence but no correlation with post-COVID syndrome
    Annick Fehrer; Franziska Sotzny; Friederike Hoheisel; Elisa Stein; Laura Kim; Claudia Kedor; Helma Freitag; Cornelia Heindrich; Sandra Bauer; Rebekka Rust; Martina Seifert; Patricia Grabowski; Nina Babel; Carmen Scheibenbogen; Kirsten Wittke

    According to the World Health Organization (WHO) and the Centers for Diseases Control and Prevention (CDC), currently an estimated 3 -6 % of people suffer from post-COVID condition or syndrome (PCS). A subset meets diagnostic criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Several studies have reported persistence of SARS-CoV-2 proteins or RNA in serum or tissues of both recovered individuals and PCS patients. In this exploratory study, we investigated whether serum spike protein is associated with PCS and whether it correlates with symptom severity and laboratory biomarkers.

    We analyzed serum spike protein levels in 121 PCS patients following mild-to-moderate COVID 19, 72 of whom met diagnostic criteria for ME/CFS (post-COVID ME/CFS, pcMECFS). Pre-pandemic seronegative healthy controls (ppHC, n = 32) and post-COVID recovered healthy controls (pcHC, n = 37) after SARS-CoV-2 infection were also included in the study.

    We found persistent serum SARS-CoV-2 spike protein in a subset of pcHC (11 %), PCS non-ME/CFS patients (2 %), and pcMECFS patients (14 %). There was no significant association with disease severity, symptoms, or laboratory markers. The spike protein concentration was independent of the time since last spike exposure (infection or vaccination). In five spike-positive out of a total of 22 patients who underwent immunoglobulin depletion via immunoadsorption (IA), spike protein was reduced or completely removed after treatment, indicating binding to immunoglobulins.

    In summary, our study identified serum spike protein in a subset of patients after SARS-CoV-2 infection without evidence for a role in the pathogenesis of PCS.


    Link | PDF (Preprint: MedRxiv) [Open Access]
     
    Kiwipom, bobbler, Kitty and 9 others like this.
  2. EndME

    EndME Senior Member (Voting Rights)

    Messages:
    1,556
    Interesting that they mention no relationship between spike protein concentration to time since last exposure. Could of course be very difficult to quantify as the correct description is likely "time since last known exposure", but I do think it contradicts some other results previously seen.
     
    Last edited: Nov 12, 2024
    Yann04, Kitty, Hutan and 2 others like this.
  3. RedFox

    RedFox Senior Member (Voting Rights)

    Messages:
    1,312
    Location:
    Pennsylvania
    This paper might be important by making the viral persistence hypothesis more difficult to support. If the authors are right, then some people have remnants of the spike protein but it has little to no influence on the disease.
     
    Kitty and pooriepoor91 like this.
  4. rvallee

    rvallee Senior Member (Voting Rights)

    Messages:
    14,568
    Location:
    Canada
    Viral persistence is probably not very significant in circulating blood. Lots of other viruses are for life, can be found in organs and some cells, how many of them are found circulating in the blood? Even their proteins?

    It limits the potential for easy identification, but I don't think it means much in terms of viral persistence.
     
    bobbler, Yann04, Utsikt and 1 other person like this.
  5. EndME

    EndME Senior Member (Voting Rights)

    Messages:
    1,556
    I think the crucial point may be that it is precisely such circumstantial evidence that lead people down the viral persistence route in the first place and thus far none of this evidence has stood the test of time (Simoa, Paxlovid etc were all the initial motivators and subsequent studies have not yielded any meaningful results).

    That doesn't mean it can't be viral persistence but perhaps instead of continuously going down the same path, initially motivated by evidence that has since been found to be noise, one ought to asks oneself is there any evidence left that makes following this path meaningful and especially what one can learn from all of the past mistakes where evidence for viral persistence was presumably based on qualitatively bad research.
     
    Wyva likes this.
  6. Mij

    Mij Senior Member (Voting Rights)

    Messages:
    10,229
    Utsikt, SNT Gatchaman and forestglip like this.
  7. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    2,528
    Location:
    Norway
    Original conclusion in abstract:
    New conclusion in abstract:
    They went from the broad ‘pathogensis of PCS’ to a more narrow ‘association with ME/CFS’.

    Why?
     
    Amw66 and Yann04 like this.
  8. Jonathan Edwards

    Jonathan Edwards Senior Member (Voting Rights)

    Messages:
    17,060
    Location:
    London, UK
    This is a very odd finding. If anything I think it casts doubt on the validity of the assays. It is hard to think of a theoretical model in which there is no decline in spike protein after exposure.

    The removal of spike protein with immunoadsorption is also peculiar.
     
  9. forestglip

    forestglip Senior Member (Voting Rights)

    Messages:
    2,096
    jcm-14-01086-g002-550.jpg

     
    Last edited: Feb 9, 2025
    SNT Gatchaman and Murph like this.
  10. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    2,528
    Location:
    Norway
    Whole blood samples from participants were allowed to clot at room temperature for at least 30 min and then centrifuged at 2000× g for 10 min at room temperature.

    @Jonathan Edwards could different clotting durations lead to different measurements?

    Room temp is also not very specific, could that affect things if the samples are processed over multiple days or periods?
     
    bobbler, alktipping and forestglip like this.
  11. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    2,528
    Location:
    Norway
    Answer: they did not assess the non-ME/CFS-PCS. The pre-print seemingly went beyond the evidence.
     
    alktipping and forestglip like this.
  12. Jonathan Edwards

    Jonathan Edwards Senior Member (Voting Rights)

    Messages:
    17,060
    Location:
    London, UK
    The results look very peculiar. There seem to be two grades of positivity.
    I have no idea how to interpret but it doesn't seem to be the secret to Long Covid.
     
    bobbler and Peter Trewhitt like this.
  13. Andy

    Andy Retired committee member

    Messages:
    23,739
    Location:
    Hampshire, UK
    New title for published version is "Serum Spike Protein Persistence Post COVID Is Not Associated with ME/CFS".
     
    Sean and Sasha like this.
  14. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights) Staff Member

    Messages:
    6,688
    Location:
    Aotearoa New Zealand
    Some other studies reporting persisting spike protein:

    Immunological and Antigenic Signatures Associated with Chronic Illnesses after COVID-19 Vaccination (2025, Preprint: MedRxiv) —

    Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis (2023, Circulation) —

    Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study (2024, Clinical Microbiology and Infection) —

     
    Sean, Dolphin and forestglip like this.

Share This Page